NDC 83980-013 – Ondansetron

Ondansetron 8 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC83980-013

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Ipca Laboratories Limited
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA209389
Marketed since
June 19, 2025
Listing expires
December 31, 2026
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (4)

Package NDCDescriptionSince
83980-013-01100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-013-01)Jun 19, 2025
83980-013-101000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-013-10)Jun 19, 2025
83980-013-1330 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-013-13)Jun 19, 2025
83980-013-833 BLISTER PACK in 1 CARTON (83980-013-83) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKJun 19, 2025

Other Ondansetron products